Context-Dependent Roles of Mutant B-Raf Signaling in Melanoma and Colorectal Carcinoma Cell Growth

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0728
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation

Cancer Research
Cancer ResearchOncology
2007English

B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells

Cancer Research
Cancer ResearchOncology
2014English

FOXD3 Is a Mutant B-Raf-Regulated Inhibitor of G1-S Progression in Melanoma Cells

Cancer Research
Cancer ResearchOncology
2010English

PIK3CA Mutation Spectrum in Urothelial Carcinoma Reflects Cell Context-Dependent Signaling and Phenotypic Outputs

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Syndecan-1 Suppresses Cell Growth and Migration via Blocking JAK1/STAT3 and Ras/Raf/Mek/Erk Pathways in Human Colorectal Carcinoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

MicroRNA‑143‑3p Suppresses Cell Growth and Invasion in Laryngeal Squamous Cell Carcinoma via Targeting the K‑Ras/Raf/Mek/Erk Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth

Frontiers in Oncology
Cancer ResearchOncology
2015English

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy